Named Patient Program (NPP) in Qatar
How the named patient program (npp) pathway operates in Qatar.
About Named Patient Program (NPP)
The foundational pathway for providing individual patients access to drugs not yet registered in their country.
How Named Patient Program (NPP) works in Qatar
Qatar's MoPH permits unregistered drug import under a named-patient pathway with physician and MoPH approval; Hamad Medical Corp frequently sponsors.
Patients in Qatar seeking access under Named Patient Program (NPP) typically follow this flow: a licensed physician in Qatar issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Qatar
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.